Sinead's Feed
Mar 15, 2012

European client pans Goldman slowness to reassure clients

LONDON, March 15 (Reuters) – APG, one of Europe’s
largest asset managers, has criticised Goldman Sachs Group Inc
for not communicating quickly enough with clients after
ex-banker Greg Smith’s public condemnation of the way the bank
treats its clients.

The Dutch investment advisor, which runs around 300 billion
euros of assets for more than 4.5 million people in the
Netherlands, said it was surprised it took the Wall Street
company more than a day to offer APG any reassurance on points
raised in Greg Smith’s resignation letter.

Mar 15, 2012

Insight: With no faith in pensions, Britons face old age poverty

LONDON (Reuters) – Erin Graham helps well-heeled 60-somethings decide whether to spend their pensions and savings on Christmas cruises in the Caribbean or summer voyages ‘on the Med’.

But the 27-year-old travel consultant knows the chances of enjoying the same lifestyle in her twilight years are slim.

Mar 15, 2012

With no faith in pensions, Britons face old age poverty

LONDON, Mar 15 (Reuters) – Erin Graham helps
well-heeled 60-somethings decide whether to spend their pensions
and savings on Christmas cruises in the Caribbean or summer
voyages ‘on the Med’.

But the 27-year-old travel consultant knows the chances of
enjoying the same lifestyle in her twilight years are slim.

Mar 12, 2012

AstraZeneca gets serious on deals as drugs run out

LONDON (Reuters) – AstraZeneca is dusting off its cheque book.

Britain’s second biggest drugmaker has bought nothing for more than $400 million (255 million pounds) since its 2007 purchase of U.S. biotechnology company MedImmune for $15.6 billion — an overpriced flop that has failed to deliver.

Now, its drug pipeline down to a trickle, the company (AZN.L: Quote, Profile, Research) is venturing back into the market and aiming for multiple low-billion-dollar deals.

Mar 9, 2012

Anaysis – AstraZeneca gets serious on deals as drugs run out

LONDON (Reuters) – AstraZeneca (AZN.L: Quote, Profile, Research) is dusting off its cheque book. The country’s second biggest drugmaker has bought nothing for more than $400 million (253 million pounds) since its 2007 purchase of U.S. biotechnology company MedImmune for $15.6 billion — an overpriced flop that has failed to deliver.

Now, its drug pipeline down to a trickle, the company is venturing back into the market and aiming for multiple low-billion-dollar deals.

Mar 5, 2012

Investors call on ECB to play fair in sovereign credit

LONDON, March 5 (Reuters) – Resentment at the European
Central Bank’s immunity from losses on Greek debt has left fund
firms wondering about the strength of their creditor rights and
whether they should blacklist bonds purchased during emergency
sprees by the lender of last resort.

By sidestepping markdowns on Greek bonds, the ECB has
effectively robbed fellow senior creditors of their top rank
status, investors say, forcing each to forgive a greater
proportion of the debt than they might otherwise have needed to.

Feb 28, 2012

Authorities risk own goal in tax fight with footballers, bankers

LONDON (Reuters) – The crackdown against tax avoidance could land the authorities with legal bills bigger than the income they recover as rich individuals, exploiting loopholes of the taxman’s own making, head to the courts to fight their corner, experts warn.

Recent scrutiny of banks and footballers has highlighted tax agencies’ over-reliance on taxpayers who confess to finding flaws in legislation and the aggressive retroactive moves against anyone who has dared to cash in on those mistakes.

Feb 28, 2012

Government risks own goal in tax fight

LONDON (Reuters) – The government’s crackdown against tax avoidance could land the authorities with legal bills bigger than the income they recover as rich individuals, exploiting loopholes of the taxman’s own making, head to the courts to fight their corner, experts warn.

Recent scrutiny of banks and footballers has highlighted British tax agencies’ over-reliance on taxpayers who confess to finding flaws in legislation and the aggressive retroactive moves against anyone who has dared to cash in on those mistakes.

Feb 28, 2012

UK risks own goal in tax fight with footballers, bankers

LONDON, Feb 28 (Reuters) – Britain’s crackdown against
tax avoidance could land the authorities with legal bills bigger
than the income they recover as rich individuals, exploiting
loopholes of the taxman’s own making, head to the courts to
fight their corner, experts warn.

Recent scrutiny of banks and footballers has highlighted
British tax agencies’ over-reliance on taxpayers who confess to
finding flaws in legislation and the aggressive retroactive
moves against anyone who has dared to cash in on those mistakes.

Feb 24, 2012

Analysis – U.S. funds ready to invest in Europe

LONDON (Reuters) – U.S. fund managers who successfully called the bottom of their home credit market in 2008 are starting to put money back into Europe in a sign of returning confidence in the euro zone.

These investors say distance is making it easier to price risk and estimate the recovery value of European assets. Their European counterparts, bruised by the region’s two-year-old debt crisis, are proving far more reticent.